Products - Psoriasis | Topic | NICE

Showing 4 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Deucravacitinib for treating active psoriatic arthritis [TSID11981]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Icotrokinra for treating moderate to severe plaque psoriasis in people 12 years and over [ID6579]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Ixekizumab for treating enthesitis-related arthritis and juvenile psoriatic arthritis in people 2 to 17 years [ID6590]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tildrakizumab for treating active psoriatic arthritis [TSID12218]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC